HumanKindLabs

HumanKindLabs is a Swedish research organization founded by chemist Ulf Bremberg (Uppsala University) that catalyzes psychedelic clinical research by optimizing therapeutic protocols around set and setting. It co-coordinates PsyPal — the first EU-funded multi-site randomised trial of psilocybin therapy, a €6.5M 19-partner consortium studying psilocybin for psychological distress in palliative care patients with COPD, MS, ALS, and atypical Parkinson’s disease.